Modulation of Vaccine-Induced Immune Responses to Hepatitis C Virus in Rhesus Macaques by Altering Priming before Adenovirus Boosting

BackgroundPreventive and therapeutic vaccine strategies aimed at controlling hepatitis C virus (HCV) infection should mimic the immune responses observed in patients who control or clear HCV, specifically T helper (Th) type 1 and CD8+ cell responses to multiple antigens, including nonstructural prot...

Full description

Saved in:
Bibliographic Details
Published inJOURNAL OF INFECTIOUS DISEASES Vol. 192; no. 5; pp. 920 - 929
Main Authors Rollier, Christine, Verschoor, Ernst J., Paranhos-Baccala, Glaucia, Drexhage, Joost A. R., Verstrepen, Babs E., Berland, Jean-Luc, Himoudi, Nourredine, Barnfield, Christina, Liljestrom, Peter, Lasarte, Juan Jose, Ruiz, Juan, Inchauspe, Genevieve, Heeney, Jonathan L.
Format Journal Article Conference Proceeding
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.09.2005
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundPreventive and therapeutic vaccine strategies aimed at controlling hepatitis C virus (HCV) infection should mimic the immune responses observed in patients who control or clear HCV, specifically T helper (Th) type 1 and CD8+ cell responses to multiple antigens, including nonstructural protein (NS) 3. Given the experience with human immunodeficiency virus, the best candidates for this are based on DNA prime, pox, or adenovirus boost regimens MethodsIn rhesus macaques, we compared NS3-expressing DNA prime and adenovirus boost strategy with 2 alternative priming approaches aimed at modifying Th1 and CD8+ responses: DNA adjuvanted with interleukin (IL)–2– and –12–encoding plasmids or Semliki Forest virus (SFV) ResultsAll prime-boost regimens elicited NS3-specific B and T cell responses in rhesus macaques, including CD8+ responses. SFV priming induced higher lymphoproliferation and longer Th1 memory responses. The use of IL-2– and IL-12–expressing vectors resulted in reduced Th2 and antibody responses, which led to increased Th1 skewing but not to an increase in the magnitude of the IFN-γ and CD8+ responses ConclusionsAll strategies induced Th1 cellular responses to HCV NS3, with fine modulations depending on the different priming approaches. When they are developed for more HCV antigens, these strategies could be beneficial in therapeutic vaccine approaches
Bibliography:ark:/67375/HXZ-9NDS2T7T-Q
istex:BF5D2CD65104322B849B2E760DFD8CA022167CFE
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1086/432517